Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
143.08
+4.29 (3.09%)
May 12, 2025, 4:00 PM - Market closed

CRL Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7,0279,52012,12711,08618,63112,521
Upgrade
Market Cap Growth
-42.82%-21.50%9.38%-40.50%48.80%68.74%
Upgrade
Enterprise Value
9,78712,11714,92114,28921,62714,493
Upgrade
Last Close Price
143.08186.16236.40217.90369.20251.71
Upgrade
PE Ratio
-924.4925.5522.8047.6534.37
Upgrade
Forward PE
14.6218.5322.7419.6633.7229.44
Upgrade
PS Ratio
1.822.352.942.795.264.28
Upgrade
PB Ratio
2.202.713.313.677.195.84
Upgrade
P/FCF Ratio
12.4818.9833.1937.5935.0232.95
Upgrade
P/OCF Ratio
9.0512.9617.7317.8924.4922.91
Upgrade
PEG Ratio
-2.521.861.652.152.45
Upgrade
EV/Sales Ratio
2.432.993.613.596.114.96
Upgrade
EV/EBITDA Ratio
11.0113.4915.4514.7424.0321.50
Upgrade
EV/EBIT Ratio
18.2322.2022.8921.4734.0933.01
Upgrade
EV/FCF Ratio
17.3824.1640.8448.4540.6538.14
Upgrade
Debt / Equity Ratio
0.920.790.861.041.141.01
Upgrade
Debt / EBITDA Ratio
3.012.782.963.023.113.03
Upgrade
Debt / FCF Ratio
5.315.548.5610.685.555.68
Upgrade
Asset Turnover
0.510.520.520.540.570.57
Upgrade
Inventory Turnover
8.078.028.1811.0311.4510.69
Upgrade
Quick Ratio
0.940.921.000.900.861.01
Upgrade
Current Ratio
1.431.411.531.321.231.43
Upgrade
Return on Equity (ROE)
-0.67%0.71%14.38%17.54%16.84%19.18%
Upgrade
Return on Assets (ROA)
4.26%4.34%5.16%5.69%6.34%5.39%
Upgrade
Return on Capital (ROIC)
5.16%5.22%6.29%7.10%8.05%6.87%
Upgrade
Return on Capital Employed (ROCE)
8.20%8.40%9.10%10.20%10.60%9.40%
Upgrade
Earnings Yield
-0.45%0.23%3.91%4.39%2.10%2.91%
Upgrade
FCF Yield
8.01%5.27%3.01%2.66%2.86%3.03%
Upgrade
Buyback Yield / Dilution
0.71%-0.34%-0.29%0.24%-1.61%-1.85%
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q